Skip to main content
Scientific American
  • Cart 0
  • Forgot password?Loading
    Not yet registered?
  • |Newsletters
Advanced Search
  • Coronavirus
  • Health
  • Mind & Brain
  • Environment
  • Technology
  • Space & Physics
  • Video
  • Podcasts
  • Opinion
  • Store
  • Subscribe
  • Current Issue
  • Cart0
  • Sign In
  • Newsletters
      • Share
      • Latest

      What's the Rx for Drug-Resistant Tuberculosis? Hard Work--And Imagination

      A rising star in public health is showing the world that the deadliest strains of tuberculosis can be treated anywhere

      • Share on Facebook
      • Share on Twitter
      • Share on Reddit
      • Share on LinkedIn
      • Share via Email
      • Print
      What's the Rx for Drug-Resistant Tuberculosis? Hard Work--And Imagination
      Slideshow (6) images
      View

      What's the Rx for Drug-Resistant Tuberculosis? Hard Work--And Imagination

        • Share
      • 6 The hospital staff wears masks to prevent infection. There is also a state-of-the-art ventilation system. The entire hospital and lab cost less than $500,000.* *Editor's note: This number has been corrected...
      • 5 Before and after: a tuberculosis laboratory built in Maseru, Lesotho in 2007.
      • 4 Before and after: an old leprosy hospital converted to treat tuberculosis patients. Hind Satti, MDR-TB program director, sits in the hallway of the renovated hospital.
      • 3 A typical road in Lesotho; the nation's population is scattered across rural highlands with poor infrastructure.
      • Advertisement
      • 2 [ from left ] Hind Satti, MDR-TB program director for Partners in Health in Lesotho; Salmaan Keshavjee; Arnold, the driver; and Likhapha Ntlamelle, a community-based care coordinator for PIH in Lesotho on a visit to a patient's home...
      • 1 Salmaan Keshavjee, physician with Partners in Health and chair of the World Health Organization's Green Light Committee. > Profile of Salmaan Keshavjee
      • Previous
      • Next
      of
      • View all
      • Link copied!
      • 6
      • 5
      • 4
      • 3
      • 2
      • 1
      Advertisement
      Advertisement

      Newsletter

      Get smart. Sign up for our email newsletter.

      Sign Up

      Support Science Journalism

      Discover world-changing science. Explore our digital archive back to 1845, including articles by more than 150 Nobel Prize winners.

      Subscribe Now!Support Science Journalism

      Follow us

      • instagram
      • soundcloud
      • youtube
      • twitter
      • facebook
      • rss

      Scientific american arabic

      العربية
      • Return & Refund Policy
      • About
      • Press Room
      • FAQs
      • Contact Us
      • Site Map
      • Advertise
      • SA Custom Media
      • Terms of Use
      • Privacy Policy
      • California Consumer Privacy Statement
      • Use of cookies/Do not sell my data
      • International Editions
      Scientific American is part of Springer Nature, which owns or has commercial relations with thousands of scientific publications (many of them can be found at www.springernature.com/us). Scientific American maintains a strict policy of editorial independence in reporting developments in science to our readers.

      © 2022 Scientific American, a Division of Springer Nature America, Inc.

      All Rights Reserved.

      Scroll To Top

      Support science journalism.

      Scientific American paper issue and on tablet

      Thanks for reading Scientific American. Knowledge awaits.

      Already a subscriber? Sign in.

      Thanks for reading Scientific American. Create your free account or Sign in to continue.

      Create Account

      See Subscription Options

      Continue reading with a Scientific American subscription.

      You may cancel at any time.

      Sign in.